# ELEVATE High-Risk PCI Pivotal Study

> **NCT07001332** · NA · RECRUITING · sponsor: **Magenta Medical Ltd.** · enrollment: 290 (estimated)

## Conditions studied

- High-Risk Percutaneous Coronary Intervention (High-risk PCI)

## Interventions

- **DEVICE:** Elevate
- **DEVICE:** Impella

## Key facts

- **NCT ID:** NCT07001332
- **Lead sponsor:** Magenta Medical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-25
- **Primary completion:** 2027-03-16
- **Final completion:** 2027-09-16
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07001332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07001332, "ELEVATE High-Risk PCI Pivotal Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07001332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*